Jinbo Yuan
Perth, WA, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Roburic acid inhibits glucocorticoid-induced osteonecrosis of the femoral head associated osteoclast activity via targeting PTP1B.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 15, 2025
Transcriptional regulation of Rankl by Txnip-Ecd in aging and diabetic related osteoporosis.
Journal: Journal of advanced research
Published: December 25, 2024
Corrigendum to "Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation" [Pharmacol. Res. 159 (2020) 104944].
Journal: Pharmacological research
Published: October 24, 2024
Targeting osteoclasts for treatment of high-risk B-cell acute lymphoblastic leukemia.
Journal: Blood cancer journal
Published: March 29, 2024
Buqi-Tongluo Decoction inhibits osteoclastogenesis and alleviates bone loss in ovariectomized rats by attenuating NFATc1, MAPK, NF-κB signaling.
Journal: Chinese journal of natural medicines
Published: March 08, 2024
Corrigendum: Inhibitory effects of Rhaponticin on osteoclast formation and resorption by targeting RANKL-induced NFATc1 and ROS activity.
Journal: Frontiers in pharmacology
Published: September 20, 2023
Age-dependent genetic regulation of osteoarthritis: independent effects of immune system genes.
Journal: Arthritis research & therapy
Published: August 16, 2023
Antidementia medication acetylcholinesterase inhibitors have therapeutic benefits on osteoporotic bone by attenuating osteoclastogenesis and bone resorption.
Journal: Journal of cellular physiology
Published: November 03, 2022
Cycloastragenol prevents bone loss via inhibiting osteoclast activity in glucocorticoid-induced osteonecrosis of the femoral head: An in vivo study.
Journal: Journal of orthopaedic translation
Published: September 24, 2022
Thiaplakortone B attenuates RANKL-induced NF-κB and MAPK signaling and dampens OVX-induced bone loss in mice.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 21, 2022
Last Updated: 09/26/2026